Skip to main content
. 2019 May 14;3(5):678–686. doi: 10.1002/bjs5.50174

Figure 3.

BJS5-50174-FIG-0003-c

Kaplan–Meier analysis of disease‐free survival in patients who had successful adjuvant FOLFOX treatment. Disease‐free survival (DFS) in upfront surgery plus adjuvant chemotherapy and perioperative chemotherapy groups a before and b after weighting. FOLFOX, 5‐fluorouracil–leucovorin–oxaliplatin. a P = 0·170, b P = 0·476 (Cox model)